⌕
AdaptHealth · AHCO · Nasdaq
Tenet 48 · Mixed
Compare
$7.53−2.59%At closeTenet 48 · Mixed
$7.53−0.20 (−2.59%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

AdaptHealth (AHCO) Income Statement

Is this a real, growing, cash-generative business, or a story propped up by accounting?

Sources Company filings FilingsHow we compute thisNot investment advice
Business engineChoppy: revenue fell 0.5% in FY25, net margin −2.2%.
The four lines that matter · FY21–FY25
Revenue ($M)▼0.5%
3,244.9
FY21→FY25CAGR +7.2%/yr
Net income ($M)—
−70.8
one-off year: see footnoteCAGR —
Free cash flow ($M)▼7.0%
219.4
FY21→FY25CAGR +32.0%/yr
Diluted EPS—
−0.52
FY21→FY25CAGR —
What the receipts whisper · what a headline number hides
Share count
+1.6%

133.0mn → 135.1mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.

Capex
$382.4M

+24.9% YoY in FY25 · 11.8% of revenue.

Returns vs FCF
3%

$7.0M returned vs $219.4M of FCF in FY25. Buybacks + dividends covered by cash flow.

What the income statement says · FY21–FY25
Where every revenue dollar goes · FY25 ($M)3244.9Revenue−2635.7COGS609.2Gross profit−382.3SG&A90.9Op income−161.7Tax & other−70.8Net income

-2¢ of every revenue dollar becomes profit. The biggest cost lever is COGS.

Margin trend · direction beats level Gross Operating Net
30231580%sector median net margin ~3%FY21FY25

Over this window: gross 18.2% → 18.8%. Net margin -2.2% is below the sector median.

The receipt · income statement · FY21–FY25 USD millions except per-share & ratios · hover a line for its definition
USD millions except per-share & ratios
Line itemTTM †FY25FY24FY23FY22FY21YoYCAGR 21→25
Revenue & profitability
Revenue
3,443.33,244.93,261.03,200.22,970.62,454.5▼0.5%+7.2%
Cost of revenue
2,898.32,635.72,579.92,576.12,390.52,008.9▲2.2%+7.0%
Gross profit
545.0609.2681.1624.1580.1445.6▼10.6%+8.1%
Selling, general & admin
392.7382.3359.2334.6324.8167.5▲6.4%+22.9%
Total operating expenses
874.6518.3417.41,222.5389.7220.0▲24.2%+23.9%
Operating incomefeeds ROC rank
−329.690.9263.7−598.4190.4225.6▼65.5%−20.3%
Other income, net
−106.4−106.0−127.7−125.4−92.5−34.6——
Pretax income
−436.0−15.2136.0−723.897.9191.0——
Income tax
−33.250.941.2−49.024.832.8▲23.4%+11.6%
Net incomePiotroski ROA ✕feeds Buffett Quality owner earnings
−406.7−70.890.4−678.969.3156.2——
Per share
Diluted EPSbuyback-sensitive
−2.98−0.520.61−5.310.330.67——
Diluted shares (mn)
136.40135.15135.53134.42138.99133.03▼0.3%+0.4%
Margins
Gross margin6th pct in Healthcare
15.8%18.8%20.9%19.5%19.5%18.2%▼2.1pp+0.6pp
Operating margin
−9.6%2.8%8.1%−18.7%6.4%9.2%▼5.3pp−6.4pp
Net margin36th pct in Healthcare
−11.8%−2.2%2.8%−21.2%2.3%6.4%▼5.0pp−8.5pp
† TTM = trailing four quarters through 2026-09-30.FY22 effective tax rate was 25% vs a 17% norm for this window, likely a one-time item; see the filing.FY23 effective tax rate was 7% vs a 17% norm for this window, likely a one-time item; see the filing.
FY18 – FY20 · 3 more years
Unlock the full history →
3 more years of statements and CSV export are on Premium.Premium · $119/yr · 7-day trial · cancel anytimeUnlock with Premium →
Annual report filed 2026-02-24 · view filings on SEC EDGAR ↗ · reported currency USD · as-filed figures may be later restated.
Statements normalized in our fundamentals DB · Not investment advice.

What was AdaptHealth's revenue last fiscal year?

AdaptHealth reported revenue of $3,244.9M in fiscal 2025, down 0.5% from fiscal 2024.

What was AdaptHealth's net income?

AdaptHealth reported net income of −$70.8M in fiscal 2025, a net margin of −2.2%.

Annual and quarterly statements as filed, normalized into one comparable shape · Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.